Clinical updates, including trial initiations, enrollment status and data readouts and publications: Roche, Seer, Singlera Genomics, Spineway.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascentage, Azurrx, Axogen, Belite, Genentech, Horizon, Regulus, Scynexis, Springworks, Talaris, Terns, TG, Transgene, Valneva.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Akebia, Algernon, Ascletis, Astrazeneca, Bioarctic, Biogen, Biontech, Calcimedica, Celltrion, China National, Dynavax, Eisai, Glaxosmithkline, Heron, Medicago, Moderna, Neurorx, Pfizer, Phasebio, Relief, Ribomic, Rigel, Santen, Synairgen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Colonaryconcepts, Sengine Precision Medicine, Teleflex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 9 Meters, Abbvie, Acadia, Aimmune, Akero, Anheart, Araim, Avenue, Biogen, Biohaven, Blue Earth, Cerecor, Cytodyn, Dragonfly, Ironwood, Larimar, Lexicon, Rafael, Staten, Xylocor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Masimo, Osteopore.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Amplyx, Arcutis, Ascletis, Astrazeneca, Basilea, Bergenbio, Bioniz, Biontech, Bioxcel, Connect, Exelixis, Lantern, Pfizer, Synairgen, Vertex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Nucleix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Aprea, Celltrion, Janssen, Phasebio, Sinopharm.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biodesix.